Reinsurance Group of America (NYSE:RGA – Get Free Report) had its target price dropped by Evercore ISI from $280.00 to ...
4d
Fintel on MSNEvercore ISI Group Upgrades CenterPoint Energy (CNP)Fintel reports that on March 11, 2025, Evercore ISI Group upgraded their outlook for CenterPoint Energy (NYSE:CNP) from ...
3d
Fintel on MSNEvercore ISI Group Initiates Coverage of Summit Therapeutics (SMMT) with Outperform RecommendationFintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...
NEW YORK, March 03, 2025--Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York.
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Factset Research (FDS – Research Report), with a ...
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Arch Capital Group (ACGL – Research Report), with ...
Evercore Group, or Lazard. Increasing Our Fair Value Estimate for Evercore to $166 From $158 Evercore’s revenue and earnings could experience a relatively tough year or two compared with the ...
Evercore ISI initiated coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat.com reports. The firm issued an ...
Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U ...
today announced that it will attend the Evercore 17th Annual Industrial Conference in New York, New York on Tuesday, March 4, 2025. Print (PRNewsfoto/Montrose Environmental Group, Inc.) ...
Fintel reports that on March 11, 2025, Evercore ISI Group upgraded their outlook for CenterPoint Energy (NYSE:CNP) from In-Line to Outperform. As of March 4, 2025, the average one-year price ...
Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. As of March 4, 2025, the average one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results